β-blockers for chest pain associated with recent cocaine use

Archives of Internal Medicine

Volumn 170, Issue 10, 2010, Pages 874-879

  Rangel, Carlos ^a   Shu, Richard G ^b   Lazar, Lawrence D ^c   Vittinghoff, Eric ^d   Hsue, Priscilla Y ^d   Marcus, Gregory M ^b  

^a Medical School   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN ANTAGONIST; ATENOLOL; BENZODIAZEPINE RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLONIDINE; COCAINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCERYL TRINITRATE; HYDRALAZINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LABETALOL; METOPROLOL; PROPRANOLOL; TROPONIN;

ADULT; ARTICLE; COCAINE DEPENDENCE; COHORT ANALYSIS; ELECTROCARDIOGRAPHY MONITORING; EMERGENCY WARD; ENDOTRACHEAL INTUBATION; FEMALE; FOLLOW UP; HEART DEATH; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTENSION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE; THORAX PAIN; URINALYSIS;

ADRENERGIC BETA-ANTAGONISTS; ADULT; CALIFORNIA; CHEST PAIN; COCAINE; COCAINE-RELATED DISORDERS; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VASOCONSTRICTOR AGENTS;

EID: 77952769825     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2010.115     Document Type: Article

References (24)

1. Office of Applied Studies. Results from the 2007 National Survey on Drug Use and Health: National Findings. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2008. NSDUH series H-34, DHHS publication No. SMA 08-4343.
2. Boehrer JD, Moliterno DJ, Willard JE, et al. Hemodynamic effects of intranasal cocaine in humans. J Am Coll Cardiol. 1992;20(1):90-93.
3. Hollander JE. The management of cocaine-associated myocardial ischemia. N Engl J Med. 1995;333(19):1267-1272.
4. Lange RA, Hillis LD. Cardiovascular complications of cocaine use. N Engl J Med. 2001;345(5):351-358.
5. Lange RA, Cigarroa RG, Flores ED, et al. Potentiation of cocaine-induced coronary vasoconstriction by beta-adrenergic blockade. Ann Intern Med. 1990; 112(12):897-903.
6. Ramoska E, Sacchetti AD. Propranolol-induced hypertension in treatment of cocaine intoxication. Ann Emerg Med. 1985;14(11):1112-1113. (Pubitemid 16201424)
7. Kloner RA, Rezkalla SH. Cocaine and the heart. N Engl J Med. 2003;348(6):487-488.
8. Antman EM, Anbe DT, Armstrong PW, et al; American College of Cardiology; American Heart Association Task Force on Practice Guidelines; Canadian Cardiovascular Society. ACC/AHA guidelines for the management of patients with STelevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation. 2004;110(9):e82-e293.
9. McCord J, Jneid H, Hollander JE, et al; American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology. Management of cocaine-associated chest pain and myocardial infarction: a scientific statement from the American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology. Circulation. 2008;117(14):1897-1907.
10. Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol. 2007;50(7):e1-e157.
11. Missouris CG, Swift PA, Singer DRJ. Cocaine use and acute left ventricular dysfunction. Lancet. 2001;357(9268):1586. (Pubitemid 32488817)
12. Sand IC, Brody SL, Wrenn KD, Slovis CM. Experience with esmolol for the treatment of cocaine-associated cardiovascular complications. AmJ Emerg Med. 1991; 9(2):161-163.
13. Boehrer JD, Moliterno DJ, Willard JE, Hillis LD, Lange RA. Influence of labetalol on cocaine-induced coronary vasoconstriction in humans. Am J Med. 1993; 94(6):608-610.
14. First International Study of Infarct Survival Collaborative Group. Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. Lancet. 1986;2(8498):57-66.
15. López-Sendón J, Swedberg K, McMurray J, et al; Task Force on Beta-Blockers of the European Society of Cardiology. Expert consensus document on beta-adrenergic receptor blockers. Eur Heart J. 2004;25(15):1341- 1362.
16. Dattilo PB, Hailpern SM, Fearon K, Sohal D, Nordin C. Beta-blockers are associated with reduced risk of myocardial infarction after cocaine use. Ann Emerg Med. 2008;51(2):117-125.
17. Wu AHB, McKay C, Broussard LA, et al; National Academy of Clinical Biochemistry Laboratory Medicine. National academy of clinical biochemistry laboratory medicine practice guidelines: recommendations for the use of laboratory tests to support poisoned patients who present to the emergency department. Clin Chem. 2003;49(3):357-379.
18. Drug Abuse Warning Network. 2006: National Estimates of Drug-Related Emergency Department Visits. Rockville, MD: Substance Abuse and Mental Health Services Administration, Office of Applied Studies; 2008. DAWN series D-30, DHHS publication No. (SMA) 08-4339.
19. Stenberg RG, Winniford MD, Hillis LD, Dowling GP, Buja LM. Simultaneous acute thrombosis of two major coronary arteries following intravenous cocaine use. Arch Pathol Lab Med. 1989;113(5):521-524.
20. Catravas JD, Waters IW. Acute cocaine intoxication in the conscious dog: studies on the mechanism of lethality. J Pharmacol Exp Ther. 1981;217(2):350-356.
21. Guinn MM, Bedford JA, Wilson MC. Antagonism of intravenous cocaine lethality in nonhuman primates. Clin Toxicol. 1980;16(4):499-508.
22. Shannon RP, Stambler BS, Komamura K, Ihara T, Vatner SF. Cholinergic modulation of the coronary vasoconstriction induced by cocaine in conscious dogs. Circulation. 1993;87(3):939-949. (Pubitemid 23070826)
23. Vargas R, Gillis RA, Ramwell PW. Propranolol promotes cocaine-induced spasm of porcine coronary artery. J Pharmacol Exp Ther. 1991;257(2):644-646.
24. Mariani PJ. Beta-blockers following cocaine use: a reappraisal. Ann Emerg Med. 2008;52(1):89-90.